Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.65 USD
+0.04 (6.72%)
Updated May 17, 2024 04:00 PM ET
After-Market: $0.65 0.00 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.15 | 0.44% |
Earnings Summary
For their last quarter, Sangamo Therapeutics (SGMO) reported earnings of -$0.27 per share, missing the Zacks Consensus Estimate of -$0.22 per share. This reflects a negative earnings surprise of 22.73%. Look out for SGMO's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.15 per share, reflecting a year-over-year increase of 59.46%.
Earnings History
Price & Consensus
Zacks News for SGMO
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
SGMO: What are Zacks experts saying now?
Zacks Private Portfolio Services